Descriere YEO:
The World\'s Medicine Chest: How - Disponibil la libris.ro
Pe YEO găsești The World\'s Medicine Chest: How de la Sally C. Pipes, în categoria Political Science.
Indiferent de nevoile tale, The World\'s Medicine Chest: How America Achieved Pharmaceutical Supremacy--And How to Keep It - Sally C. Pipes din categoria Political Science îți poate aduce un echilibru perfect între calitate și preț, cu avantaje practice și moderne.
Preț: 139.45 Lei
Caracteristicile produsului The World\'s Medicine Chest: How
- Brand: Sally C. Pipes
- Categoria: Political Science
- Magazin: libris.ro
- Ultima actualizare: 18-09-2025 01:36:55
Comandă The World\'s Medicine Chest: How Online, Simplu și Rapid
Prin intermediul platformei YEO, poți comanda The World\'s Medicine Chest: How de la libris.ro rapid și în siguranță. Bucură-te de o experiență de cumpărături online optimizată și descoperă cele mai bune oferte actualizate constant.
Descriere magazin:
The
World\'s
Medicine Chest details how
America became the world\'s leader in biopharmaceutical innovation and reveals how new threats to this industry will have disastrous consequences for patients and the U.S. economy. In the 1970s, Europe was the global hub for pharmaceutical innovation. European drug companies developed more than twice as many drugs in that decade as their U.S.-based counterparts. But times have changed. Today, nearly half of all new drugs come from the United States. Just 22 percent are of European origin. And U.S. patients get access to innovative medicines before anyone else in the world. Drawing on her decades of experience as a health policy scholar,
Sally Pipes details how
America became the world\'s leader in biopharmaceutical innovation. She argues that efforts over the last few years by Democrats and Republicans alike to impose price controls on prescription drugs will have disastrous consequences for patients and for the U.S. Economy. The
World\'s
Medicine Chest details how
America became the world\'s leader in biopharmaceutical innovation and reveals how new threats to this industry will have disastrous consequences for patients and the U.S. economy. In the 1970s, Europe was the global hub for pharmaceutical innovation. European drug companies developed more than twice as many drugs in that decade as their U.S.-based counterparts. But times have changed. Today, nearly half of all new drugs come from the United States. Just 22 percent are of European origin. And U.S. patients get access to innovative medicines before anyone else in the world. Drawing on her decades of experience as a health policy scholar,
Sally Pipes details how America became the world\'s leader in biopharmaceutical innovation. She argues that efforts over the last few years by Democrats and Republicans alike to impose price controls on prescription drugs will have disastrous consequences for patients and for the U.S. Economy.